US Patent 8486956 Forms of rifaximin and uses thereof
Patent 8486956 was granted and assigned to Salix Pharmaceuticals on July, 2013 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8486956 Forms of rifaximin and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
